Verity Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $520K | Buy |
1,717
+157
| +10% | +$47.5K | 0.25% | 100 |
|
|
2025
Q1 | $517K | Buy |
1,560
+70
| +5% | +$23.2K | 0.21% | 110 |
|
|
2024
Q4 | $460K | Buy |
1,490
+24
| +2% | +$7.41K | 0.26% | 90 |
|
|
2024
Q3 | $311K | Buy |
1,466
+101
| +7% | +$21.4K | 0.12% | 154 |
|
|
2024
Q2 | $382K | Sell |
1,365
-209
| -13% | -$58.6K | 0.15% | 125 |
|
|
2024
Q1 | $420K | Sell |
1,574
-1,115
| -41% | -$298K | 0.23% | 113 |
|
|
2023
Q4 | $622K | Buy |
2,689
+2
| +0.1% | +$463 | 0.4% | 64 |
|
|
2023
Q3 | $392K | Buy |
2,687
+721
| +37% | +$105K | 0.29% | 92 |
|
|
2023
Q2 | $454K | Buy |
1,966
+492
| +33% | +$114K | 0.34% | 82 |
|
|
2023
Q1 | $357K | Buy |
1,474
+452
| +44% | +$110K | 0.21% | 109 |
|
|
2022
Q4 | $297K | Sell |
1,022
-2,830
| -73% | -$821K | 0.25% | 118 |
|
|
2022
Q3 | $250K | Buy |
+3,852
| New | +$250K | 0.26% | 125 |
|
|
2022
Q1 | $275K | Buy |
2,801
+145
| +5% | +$14.2K | 0.17% | 157 |
|
|
2021
Q4 | $225K | Sell |
2,656
-320
| -11% | -$27.1K | 0.13% | 178 |
|
|
2021
Q3 | $237K | Buy |
2,976
+618
| +26% | +$49.2K | 0.15% | 159 |
|
|
2021
Q2 | $230K | Buy |
2,358
+49
| +2% | +$4.78K | 0.13% | 198 |
|
|
2021
Q1 | $270K | Buy |
2,309
+464
| +25% | +$54.3K | 0.16% | 166 |
|
|
2020
Q4 | $205K | Buy |
+1,845
| New | +$205K | 0.14% | 151 |
|
|
2015
Q4 | – | Sell |
-1,842
| Closed | -$112K | – | 90 |
|
|
2015
Q3 | $112K | Sell |
1,842
-492
| -21% | -$29.9K | 0.11% | 88 |
|
|
2015
Q2 | $182K | Buy |
2,334
+719
| +45% | +$56.1K | 0.16% | 85 |
|
|
2015
Q1 | $110K | Sell |
1,615
-739
| -31% | -$50.3K | 0.11% | 78 |
|
|
2014
Q4 | $218K | Sell |
2,354
-63
| -3% | -$5.83K | 0.21% | 68 |
|
|
2014
Q3 | $254K | Sell |
2,417
-412
| -15% | -$43.3K | 0.29% | 52 |
|
|
2014
Q2 | $405K | Sell |
2,829
-114
| -4% | -$16.3K | 0.44% | 44 |
|
|
2014
Q1 | $456K | Buy |
2,943
+218
| +8% | +$33.8K | 0.47% | 35 |
|
|
2013
Q4 | $500K | Buy |
+2,725
| New | +$500K | 0.55% | 23 |
|